- €1.71bn
- €4.15bn
- €2.93bn
- 28
- 46
- 55
- 34
Annual balance sheet for Eramet SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PRESS | ARS | ARS | ARS | ARS |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,811 | 1,176 | 1,660 | 1,606 | 913 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 362 | 388 | 375 | 231 | 264 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3,431 | 3,116 | 3,982 | 2,972 | 2,412 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,207 | 2,321 | 2,298 | 2,306 | 2,901 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 6,443 | 6,243 | 7,159 | 6,276 | 6,464 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,509 | 2,149 | 2,516 | 1,752 | 1,471 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 5,718 | 5,231 | 5,378 | 4,676 | 5,023 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 725 | 1,012 | 1,781 | 1,600 | 1,441 |
| Total Liabilities & Shareholders' Equity | 6,443 | 6,243 | 7,159 | 6,276 | 6,464 |
| Total Common Shares Outstanding |